MEDXF News and Press, Medexus Pharmaceuticals Inc From 08/10/21

TORONTO and CHICAGO, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “ Company ” or “Medexus ”) (TSX: MDP) (OTCQX: MEDXF) today announced that it plans to host a conference call at 8:00 AM Eastern Time on Tuesday, August 17, 2021 t...

TORONTO and CHICAGO, Aug. 09, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “ Company ” or “Medexus ”) (TSX: MDP) (OTCQX: MEDXF) announced today that it will be presenting at the Canaccord Genuity 41 st Annual Growth Conference being held...

TORONTO and CHICAGO, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (“ Medexus ” or the “ Company ”) (TSX: MDP) (OTCQX: MEDXF) today announced that it has scheduled a webinar on Thursday, August 5, 2021 at 10:00 a.m. Eastern Time to discus...

TORONTO and CHICAGO and WEDEL, Germany, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (“ Medexus ” or the “ Company ”) (TSX: MDP) (OTCQX: MEDXF) and medac GmbH (“medac”) announced today that medac, Medexus’ licensor f...

TORONTO and CHICAGO, July 19, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (“Medexus” or the “Company”) (TSX: MDP) (OTCQX: MEDXF) is pleased to announce the appointment of Marcel Konrad as Chief Financial Officer of the Company, effective immediately. Mr...

Medexus Pharmaceuticals ([[MEDXF]]) announces that it has entered into a licensing agreement with medac GmbH to commercialize treosulfan, a bifunctional alkylating agent, in Canada.Treosulfan will be marketed in Canada under the brand name Trecondyv and indicated in combin...

TORONTO and CHICAGO and WEDEL, Germany, July 12, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “ Company ” or “ Medexus ”) (TSX: MDP) (OTCQX: MEDXF) today announced that it has entered into a licensing agreement, formalizing its relation...

Medexus Pharmaceuticals (MEDXF) has received a Notice of Compliance (“NOC”) from Health Canada to commercialize treosulfan, developed by medac GmbH, in Canada.Treosulfan will be marketed in Canada under the brand name Trecondyv and indicated in combinati...

TORONTO and CHICAGO, June 28, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “ Company ” or “ Medexus ”) (TSX: MDP) (OTCQX: MEDXF) today announced that it has received a Notice of Compliance (“ NOC ”) from Health Canada ...

Start Time: 08:00 End Time: 08:41 Medexus Pharmaceuticals Inc. (MEDXF) Q4 2021 Earnings Conference Call June 17, 2021, 08:00 AM ET Company Participants Ken d’Entremont - CEO Roland Boivin - CFO Tina Byers - IR Conference Call Participants Andre Uddin - Research Capital Justin Keywood -...